Bone Biologics Corp (BBLG)
1.66
+0.11
(+7.10%)
USD |
NASDAQ |
May 31, 16:00
1.64
-0.02
(-1.20%)
After-Hours: 20:00
Bone Biologics Enterprise Value: -1.401M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | -1.401M |
| May 30, 2024 | -1.522M |
| May 29, 2024 | -1.522M |
| May 28, 2024 | -1.478M |
| May 24, 2024 | -1.577M |
| May 23, 2024 | -1.566M |
| May 22, 2024 | -1.555M |
| May 21, 2024 | -1.621M |
| May 20, 2024 | -1.225M |
| May 17, 2024 | -1.159M |
| May 16, 2024 | -0.8065M |
| May 15, 2024 | -0.7295M |
| May 14, 2024 | -0.6965M |
| May 13, 2024 | -1.137M |
| May 10, 2024 | -1.115M |
| May 09, 2024 | -1.247M |
| May 08, 2024 | -1.388M |
| May 07, 2024 | -1.439M |
| May 06, 2024 | -1.367M |
| May 03, 2024 | -1.347M |
| May 02, 2024 | -1.350M |
| May 01, 2024 | -1.520M |
| April 30, 2024 | -1.640M |
| April 29, 2024 | -1.637M |
| April 26, 2024 | -1.672M |
| Date | Value |
|---|---|
| April 25, 2024 | -1.683M |
| April 24, 2024 | -1.677M |
| April 23, 2024 | -1.601M |
| April 22, 2024 | -1.601M |
| April 19, 2024 | -1.591M |
| April 18, 2024 | -1.403M |
| April 17, 2024 | -1.428M |
| April 16, 2024 | -1.449M |
| April 15, 2024 | -1.591M |
| April 12, 2024 | -1.522M |
| April 11, 2024 | -1.530M |
| April 10, 2024 | -1.561M |
| April 09, 2024 | -1.500M |
| April 08, 2024 | -1.418M |
| April 05, 2024 | -1.469M |
| April 04, 2024 | -1.408M |
| April 03, 2024 | -1.235M |
| April 02, 2024 | -1.195M |
| April 01, 2024 | -1.062M |
| March 28, 2024 | -1.154M |
| March 27, 2024 | -1.233M |
| March 26, 2024 | -1.180M |
| March 25, 2024 | -1.075M |
| March 22, 2024 | -1.048M |
| March 21, 2024 | -1.092M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-5.211M
Minimum
Jun 15 2023
69.19M
Maximum
Nov 01 2021
7.108M
Average
-1.087M
Median
Jan 25 2024
Enterprise Value Benchmarks
| BioVie Inc | 4.933M |
| Adial Pharmaceuticals Inc | 1.071M |
| NovaBay Pharmaceuticals Inc | 4.387M |
| Palatin Technologies Inc | 19.03M |
| iBio Inc | 28.91M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.866M |
| Total Expenses (Quarterly) | 0.9035M |
| EPS Diluted (Quarterly) | -1.31 |
| Earnings Yield | -1.36K% |